$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000165130821000223 Filed on November 04, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$1.362B	$206.4M	$91.08M
YoY Change	1261.08%	126.66%	81.65%
Cost Of Revenue	$329.3M	$47.41M	$21.12M
YoY Change	116.72%	124.46%	5.06%
Gross Profit	$1.033B	$159.0M	$69.96M
YoY Change	102.73%	127.32%	132.92%
Gross Profit Margin	75.83%	77.03%	76.81%
Selling, General & Admin	$2.194B	$269.2M	$160.8M
YoY Change	60.31%	67.39%	53.18%
% of Gross Profit	212.34%	169.3%	229.91%
Research & Development	$2.825B	$351.9M	$349.1M
YoY Change	29.75%	0.82%	47.31%
% of Gross Profit	273.45%	221.31%	498.98%
Depreciation & Amortization	$192.8M	$11.77M	$8.157M
YoY Change	8.31%	44.33%	121.0%
% of Gross Profit	18.66%	7.4%	11.66%
Operating Expenses	$5.177B	$621.2M	$509.9M
YoY Change	39.34%	21.82%	49.11%
Operating Profit	-$4.144B	-$462.3M	-$440.1M
YoY Change	754.65%	5.04%	40.95%
Interest Expense	-$119.1M	$130.7M	$185.4M
YoY Change	-1693.08%	-29.5%
% of Operating Profit
Other Income/Expense, Net	$287.0K	$31.48M	$5.711M
YoY Change	-265.9%	451.16%	-414.31%
Pretax Income	-$4.263B	-$433.1M	-$435.0M
YoY Change	33.29%	-0.45%	39.49%
Income Tax	-$16.17M	-$19.22M	-$8.423M
% Of Pretax Income
Net Earnings	-$4.247B	-$413.9M	-$425.2M
YoY Change	798.44%	-2.67%	38.35%
Net Earnings / Revenue	-311.74%	-200.47%	-466.87%
Basic Earnings Per Share		-$0.34	-$0.37
Diluted Earnings Per Share	-$3.182M	-$2.253M	-$6.071M
COMMON SHARES
Basic Shares Outstanding	1.220B shares	1.206B shares	1.149B shares
Diluted Shares Outstanding		1.206B shares	1.149B shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.618B	$3.917B	$4.719B
YoY Change	42.29%	-16.99%
Cash & Equivalents	$4.376B	$1.383B	$1.464B
Short-Term Investments	$2.242B	$2.534B	$3.254B
Other Short-Term Assets	$27.06M	$1.086B
YoY Change	131.96%
Inventory	$242.6M	$151.0M	$35.53M
Prepaid Expenses
Receivables	$483.1M	$129.6M	$60.27M
Other Receivables	$12.01M	$2.829M
Total Short-Term Assets	$7.614B	$4.433B	$4.966B
YoY Change	53.48%	-10.73%	245.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$587.6M	$450.8M	$291.2M
YoY Change	64.28%	54.79%	28.57%
Goodwill	$109.0K	$109.0K	$109.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$22.96M	$566.4M	$36.76M
YoY Change		1441.08%
Other Assets	$163.0M	$175.1M	$162.6M
YoY Change	44.18%	7.7%	150.74%
Total Long-Term Assets	$1.032B	$853.5M	$600.7M
YoY Change	61.24%	42.09%	34.82%
TOTAL ASSETS
Total Short-Term Assets	$7.614B	$4.433B	$4.966B
Total Long-Term Assets	$1.032B	$853.5M	$600.7M
Total Assets	$8.646B	$5.286B	$5.566B
YoY Change	54.37%	-5.03%	195.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$262.4M	$206.2M	$146.3M
YoY Change	13.12%	40.98%	30.27%
Accrued Expenses	$558.1M	$389.9M	$279.3M
YoY Change	61.22%	39.58%
Deferred Revenue	$187.4M	$72.63M
YoY Change
Short-Term Debt	$2.622B	$2.760B
YoY Change	682.62%
Long-Term Debt Due	2.725B cnies	2.850B CNies	$50.22M
YoY Change	24.65%	5575.47%	7074.57%
Total Short-Term Liabilities	$1.600B	$1.304B	$645.7M
YoY Change	48.77%	102.01%	143.0%
LONG-TERM LIABILITIES
Long-Term Debt	1.288B cnies	1.295B CNies	$151.6M
YoY Change	7.49%	754.17%	45.4%
Other Long-Term Liabilities	$54.23M	$54.61M	$47.89M
YoY Change	-5.56%	14.02%	30.92%
Total Long-Term Liabilities	$803.4M	$624.8M	$624.2M
YoY Change	22.41%	0.11%	94.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.600B	$1.304B	$645.7M
Total Long-Term Liabilities	$803.4M	$624.8M	$624.2M
Total Liabilities	$2.403B	$1.929B	$1.270B
YoY Change	38.78%	51.93%	116.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.966B	-$4.380B	-$3.080B
YoY Change	39.78%	42.22%	96.46%
Common Stock	$133.0K	$121.0K	$118.0K
YoY Change	12.71%	2.54%	51.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.243B	$3.357B	$4.287B
YoY Change
Total Liabilities & Shareholders Equity	$8.646B	$5.286B	$5.566B
YoY Change	54.37%	-5.03%	195.92%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$4.247B	-$413.9M	-$425.2M
YoY Change	798.44%	-2.67%	38.35%
Depreciation, Depletion And Amortization	$192.8M	$11.77M	$8.157M
YoY Change	8.31%	44.33%	121.0%
Cash From Operating Activities	-$3.109B	-$3.228B	-$2.755B
YoY Change	28.25%	17.17%
INVESTING ACTIVITIES
Capital Expenditures	-$1.240B	-$407.0M	-$693.9M
YoY Change	315.92%	-41.34%
Acquisitions
YoY Change
Other Investing Activities	$231.6M	$1.342B	-$21.35B
YoY Change	-52.51%	-106.28%
Cash From Investing Activities	-$1.009B	$934.7M	-$22.05B
YoY Change	-632.43%	-104.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.46B	632.2M	29.22B
YoY Change	899.43%	-97.84%
NET CHANGE
Cash From Operating Activities	-3.109B	-3.228B	-2.755B
Cash From Investing Activities	-1.009B	934.7M	-22.05B
Cash From Financing Activities	21.46B	632.2M	29.22B
Net Change In Cash	17.34B	-1.661B	4.422B
YoY Change	-19856.64%	-137.57%
FREE CASH FLOW
Cash From Operating Activities	-$3.109B	-$3.228B	-$2.755B
Capital Expenditures	-$1.240B	-$407.0M	-$693.9M
Free Cash Flow	-$1.869B	-$2.821B	-$2.061B
YoY Change	-12.09%	36.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37686
	dei	Entity Registrant Name EntityRegistrantName	BEIGENE, LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1209416
	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Mourant Governance Services (Cayman) Limited
	dei	Entity Address Address Line2 EntityAddressAddressLine2	94 Solaris Avenue, Camana Bay
	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
	dei	Entity Address Country EntityAddressCountry	KY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1108
	dei	City Area Code CityAreaCode	345
	dei	Local Phone Number LocalPhoneNumber	949-4123
	dei	Security12b Title Security12bTitle	American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	BGNE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1219734201	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1383310000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1381950000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	330000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	307000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2533617000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3268725000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	129584000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60403000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	150979000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	89293000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	235015000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	160012000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	4432835000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	4960690000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6056000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	65962000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	175122000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7748000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	450788000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357686000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	100585000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	90581000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14104000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	106844000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113090000	USD
CY2021Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	853499000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	640067000	USD
CY2021Q3	us-gaap	Assets Assets	5286334000	USD
CY2020Q4	us-gaap	Assets Assets	5600757000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	206203000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	231957000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	389874000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	346144000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	72626000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	USD
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	20878000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	20380000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18644000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13895000	USD
CY2021Q3	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	153838000	USD
CY2020Q4	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	127808000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	442372000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	335015000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1304435000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1075199000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	200906000	USD
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1213234201	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1190821941	shares
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29417000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13266000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	183637000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	52272000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37613000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10792000	USD
CY2021Q3	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	266163000	USD
CY2020Q4	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	375040000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54606000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	57429000	USD
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	624826000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	656315000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	1929261000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1731514000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1213234201	shares
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1136218000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19223000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8423000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24083000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8344000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-413855000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-426617000	USD
	us-gaap	Profit Loss ProfitLoss	-827701000	USD
	us-gaap	Profit Loss ProfitLoss	-1127874000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	208774000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47413000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21123000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	116361000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49579000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	351937000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	349070000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1028754000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	939340000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	269227000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	160837000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	683622000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	391967000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	668765000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	531217000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1829300000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1381544000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-462325000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-440137000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-866996000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1172770000	USD
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2230000	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-614000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11275000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7184000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	31477000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5711000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	26487000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29368000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-433078000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-435040000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-851784000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1393000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3713000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-413855000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-425224000	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1190821941	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	121000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	118000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7724822000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7414932000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	12580000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6942000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4380450000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3552749000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	3357073000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3869243000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5286334000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5600757000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	206440000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91080000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	962304000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-827701000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1124161000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1205971284	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1205971284	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1148973077	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1148973077	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1196391201	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1196391201	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1052940583	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1052940583	shares
CY2021Q3	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	-4.46
CY2020Q3	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	-4.81
	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	-8.99
	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	-13.88
CY2021Q3	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	92767022	shares
CY2021Q3	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	92767022	shares
CY2020Q3	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	88382544	shares
CY2020Q3	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	88382544	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	92030092	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	92030092	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	80995429	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	80995429	shares
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-413855000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-426617000	USD
	us-gaap	Profit Loss ProfitLoss	-827701000	USD
	us-gaap	Profit Loss ProfitLoss	-1127874000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	664000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10143000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6528000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7526000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	111000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-250000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-68000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1044000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1140000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	184000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-413370000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-417518000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-822063000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1120164000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1174000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-3585000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-413370000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-416344000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-822063000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1116579000	USD
	us-gaap	Profit Loss ProfitLoss	-827701000	USD
	us-gaap	Profit Loss ProfitLoss	-1127874000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33336000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23961000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	177701000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	134020000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	17166000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9974000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	53500000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	89500000	USD
	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-82846000	USD
	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-85296000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-38408000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-8762000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	17719000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-10163000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	69174000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10497000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	61686000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6972000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	92938000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	58921000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12376000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	21979000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	819000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	103600000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	124898000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3438000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-26722000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-790884000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-951127000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	147963000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	82819000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2062879000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	4879705000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2758391000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1972608000	USD
	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	8500000	USD
	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	89500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7500000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2025000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	531549000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3081441000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4232017000	USD
	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	0	USD
	bgne	Proceeds From Research And Development Financing Liability ProceedsFromResearchAndDevelopmentFinancingLiability	616834000	USD
	bgne	Prepayment To Acquire Joint Venture Minority Interest PrepaymentToAcquireJointVentureMinorityInterest	0	USD
	bgne	Prepayment To Acquire Joint Venture Minority Interest PrepaymentToAcquireJointVentureMinorityInterest	28723000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	16838000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	64288000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	132061000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	143456000	USD
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	48983000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	40229000	USD
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	82192000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	75830000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252257000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4877168000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6769000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4340000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-309000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	848940000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1390005000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	620775000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1389696000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1469715000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1383310000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1464470000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	330000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	295000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6056000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4950000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15214000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10596000	USD
	us-gaap	Interest Paid Net InterestPaidNet	23398000	USD
	us-gaap	Interest Paid Net InterestPaidNet	41577000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	41897000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30926000	USD
	bgne	Acquired In Process Research And Development But Not Yet Paid AcquiredInProcessResearchAndDevelopmentButNotYetPaid	45000000	USD
	bgne	Acquired In Process Research And Development But Not Yet Paid AcquiredInProcessResearchAndDevelopmentButNotYetPaid	20000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3869243000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25754000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45833000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3738000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4003587000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	9847000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64791000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8891000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-480341000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3606775000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	46591000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67077000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	485000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-413855000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3357073000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	978355000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	11629000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38255000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1349000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-364939000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2827056000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	16569000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45468000	USD
CY2020Q2	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	3545000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2738000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-336318000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2546492000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	47632000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50297000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9099000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-426617000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4296514000	USD
CY2021Q3	bgne	Number Of Molecules NumberOfMolecules	10	molecule
CY2021Q3	bgne	Number Of Persons NumberOfPersons	1800	people
CY2021Q3	bgne	Product Candidate ProductCandidate	3	product
CY2021Q3	bgne	Products In Commercial Or Clinical Development ProductsInCommercialOrClinicalDevelopment	45	product
CY2021Q3	dei	Entity Number Of Employees EntityNumberOfEmployees	7600	employee
CY2021Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	23	country
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2021Q3	bgne	Reimbursement Expense ReimbursementExpense	12545000	USD
CY2020Q3	bgne	Reimbursement Expense ReimbursementExpense	4629000	USD
	bgne	Reimbursement Expense ReimbursementExpense	27721000	USD
	bgne	Reimbursement Expense ReimbursementExpense	4629000	USD
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	6386000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	8055000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2533886000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	269000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2533617000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3267875000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	850000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	3268725000	USD
CY2021Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	21714000	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	9705000	USD
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	54993000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19330000	USD
CY2021Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10397000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1378000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	11773000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68585000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	150979000	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	85589000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	89293000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	431517000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	345261000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	110086000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	73354000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	450788000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357686000	USD
CY2021Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	129357000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	85779000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1695000	USD
	us-gaap	Depreciation Depreciation	32440000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	8157000	USD
	us-gaap	Depreciation Depreciation	23303000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	18316000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4212000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14104000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8316000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3316000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5000000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	187000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	896000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	658000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	424000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1695000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1695000	USD
CY2021Q3	bgne	Finite Lived Intangible Asset Expected Amortization After Year Three FiniteLivedIntangibleAssetExpectedAmortizationAfterYearThree	8595000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19223000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-24083000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8423000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8344000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9084000	USD
CY2021Q3	bgne	Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives	778000	USD
	bgne	Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives	1961000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	112000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	114000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	3000	USD
	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	0	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	108000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	114000	USD
CY2021Q3	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	75696000	USD
CY2020Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	71341000	USD
CY2021Q3	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	59536000	USD
CY2020Q4	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	25996000	USD
CY2021Q3	us-gaap	Prepaid Taxes PrepaidTaxes	38438000	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	30392000	USD
CY2021Q3	bgne	Payroll Tax Receivable Current PayrollTaxReceivableCurrent	20911000	USD
CY2020Q4	bgne	Payroll Tax Receivable Current PayrollTaxReceivableCurrent	3580000	USD
CY2021Q3	bgne	Prepaid Commercial Costs PrepaidCommercialCosts	7646000	USD
CY2020Q4	bgne	Prepaid Commercial Costs PrepaidCommercialCosts	2794000	USD
CY2021Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	7223000	USD
CY2020Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	6619000	USD
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	4122000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1347000	USD
CY2021Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3016000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4607000	USD
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2829000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	4464000	USD
CY2021Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	15598000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	8872000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	235015000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	160012000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	109000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2021Q3	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	34579000	USD
CY2020Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	16984000	USD
CY2021Q3	bgne	Prepaid Construction Cost PrepaidConstructionCost	23816000	USD
CY2020Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	29778000	USD
CY2021Q3	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	21499000	USD
CY2020Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	10913000	USD
CY2021Q3	bgne	Rental Deposits And Other RentalDepositsAndOther	7691000	USD
CY2020Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	5962000	USD
CY2021Q3	us-gaap	Long Term Investments LongTermInvestments	87428000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	49344000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	175122000	USD
CY2020Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	143302000	USD
CY2021Q3	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	67100000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113090000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	104878000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	106765000	USD
CY2021Q3	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	163937000	USD
CY2020Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	66131000	USD
CY2021Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	27494000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	14373000	USD
CY2021Q3	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	20190000	USD
CY2020Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	11874000	USD
CY2021Q3	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	6275000	USD
CY2020Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	3699000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	389874000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	346144000	USD
CY2021Q3	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	46672000	USD
CY2020Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	49139000	USD
CY2021Q3	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7863000	USD
CY2020Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	8113000	USD
CY2021Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	71000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	177000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54606000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	57429000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	442372000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	2850335000	CNY
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	335015000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2185928000	CNY
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	200906000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1294500000	CNY
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	183637000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1198206000	CNY
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	7609000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	22186000	USD
CY2021Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	275000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	526000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	4139000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	12849000	USD
CY2020Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	97000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	214000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-413855000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-426617000	USD
	us-gaap	Profit Loss ProfitLoss	-827701000	USD
	us-gaap	Profit Loss ProfitLoss	-1127874000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1393000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3713000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-413855000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-425224000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-827701000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1124161000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1205971284	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1205971284	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1148973077	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1148973077	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1196391201	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1196391201	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1052940583	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1052940583	shares
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	67077000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50297000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	177701000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	134020000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5700000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	62000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5638000	USD
CY2021Q3	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2021Q3	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.50
CY2021Q3	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	268498000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	206440000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	91080000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	962304000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	208774000	USD
CY2021Q3	dei	Entity Number Of Employees EntityNumberOfEmployees	7600	employee

Files In Submission

Name	View Source	Status
0001651308-21-000223-index-headers.html	Edgar Link	pending
0001651308-21-000223-index.html	Edgar Link	pending
0001651308-21-000223.txt	Edgar Link	pending
0001651308-21-000223-xbrl.zip	Edgar Link	pending
bgne-20210930.htm	Edgar Link	pending
bgne-20210930.xsd	Edgar Link	pending
bgne-20210930_cal.xml	Edgar Link	unprocessable
bgne-20210930_def.xml	Edgar Link	unprocessable
bgne-20210930_htm.xml	Edgar Link	completed
bgne-20210930_lab.xml	Edgar Link	unprocessable
bgne-20210930_pre.xml	Edgar Link	unprocessable
exhibit311-2021q3.htm	Edgar Link	pending
exhibit312-2021q3.htm	Edgar Link	pending
exhibit321-2021q3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2021 Q4 Form 10-Q Financial Statement

#000165130821000223 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2021 Q4 Form 10-Q Financial Statement

#000165130821000223 Filed on November 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc